×

TESARO to Participate in Several Upcoming Investor Conferences

TESARO, Inc. Logo

WALTHAM, Mass., Aug. 30, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, announced that Lonnie Moulder, CEO of TESARO, and Mary Lynne Hedley, Ph.D., President of TESARO, will participate in several upcoming investor conferences during the month of September, including:

  • Citi's 8th Annual Biotech Day at the Mandarin Oriental Hotel in Boston on Wednesday, September 4, 2013
  • The JMP Securities Biotech Day at the Langham Hotel in Boston on Friday, September 6, 2013 at 11:30 a.m. EDT.
  • Baird's 2013 Health Care Conference at The New York Palace Hotel in New York City on Tuesday, September 10, 2013 at 1:45 p.m. EDT. A live webcast will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. An archived replay of the webcast will be available on the Company's website for 14 days after the conference. The Company will also participate on a panel titled "Oncology Drug Pricing – Positioning for Success in a Rapidly Changing Reimbursement Landscape" on Wednesday, September 11, 2013 at 12:10 p.m. EDT.
  • The Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York City on Wednesday, September 11, 2013 at 1:30 p.m. EDT. A live webcast will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. An archived replay of the webcast will be available on the Company's website for 14 days after the conference.

About TESARO

TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.

CONTACT: Jennifer Davis Sr. Director, Corporate Development & Investor Relations 1.781.325.1116 jdavis@tesarobio.com

Source:TESARO, Inc.